Dual Targeted Immunotherapy via in Vivo Delivery of Biohybrid RNAi-Peptide Nanoparticles to Tumor-Associated Macrophages and Cancer Cells
- Submitting institution
-
Queen Mary University of London
- Unit of assessment
- 12 - Engineering
- Output identifier
- 567
- Type
- D - Journal article
- DOI
-
10.1002/adfm.201501283
- Title of journal
- Advanced Functional Materials
- Article number
- -
- First page
- 4183
- Volume
- 25
- Issue
- 27
- ISSN
- 1616-301X
- Open access status
- Out of scope for open access requirements
- Month of publication
- June
- Year of publication
- 2015
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
8
- Research group(s)
-
-
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- The paper derives from a EU FP7 Marie Curie Fellowship “CancerHydrogelPatch” (Project N°: 626386) and the project was featured in three publications by the European Commission (HORIZON – The EU Research and Innovation magazine, May 2016 https://horizon-magazine.eu/article/disappearing-implants-might-just-save-your-life.html; CORDIS website, September 2017, https://cordis.europa.eu/project/rcn/186301/brief/en - article available in several languages: DE, EN, ES, FR, IT, PL; R&I website, November 2017, https://ec.europa.eu/research/infocentre/article_en.cfm?id=/research/headlines/news/article_17_11_14-2_en.html?infocentre&item=Infocentre&artid=46417). This publication was featured in the journal cover and was key for the first author to get an ERC Starting Grant (GelGeneCircuit, Grant ID: 848325, €1,435,312) and faculty position at NOVA Medical School, Universidade Nova de Lisboa (Portugal).
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -